Cogent Biosciences, Inc. (COGT) DCF Valuation

Cogent Biosciences, Inc. (COGT) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Cogent Biosciences, Inc. (COGT) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Cogent Biosciences, Inc. (COGT) financial outlook like an expert! This (COGT) DCF Calculator provides pre-filled financial data and offers full flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 22.5 7.9 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -65.02 -100 0 0 -41.25 -41.25 -41.25 -41.25 -41.25
EBITDA -30.9 -34.6 -75.4 -134.4 -205.9 .0 .0 .0 .0 .0
EBITDA, % -137.27 -439.19 100 100 100 20 20 20 20 20
Depreciation 1.3 .7 .1 5.9 2.3 .0 .0 .0 .0 .0
Depreciation, % 5.75 9.15 100 100 100 62.98 62.98 62.98 62.98 62.98
EBIT -32.2 -35.3 -75.6 -140.2 -208.1 .0 .0 .0 .0 .0
EBIT, % -143.02 -448.34 100 100 100 20 20 20 20 20
Total Cash 37.4 242.2 219.7 259.3 265.7 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 2.0 .0 .0 .0 .0
Account Receivables, % 8.89 0 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 0 100 100 100 60 60 60 60 60
Accounts Payable 3.2 .7 3.5 5.8 10.7 .0 .0 .0 .0 .0
Accounts Payable, % 14.15 9.3 100 100 100 64.69 64.69 64.69 64.69 64.69
Capital Expenditure .0 .0 -1.7 -6.9 -2.8 .0 .0 .0 .0 .0
Capital Expenditure, % -0.14667 0 100 100 100 -0.02933464 -0.02933464 -0.02933464 -0.02933464 -0.02933464
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -30.6 -31.3 -75.1 -132.6 -208.1 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -28.2 -31.1 -73.9 -131.3 -203.8 -10.7 .0 .0 .0 .0
WACC, % 5.36 5.35 5.37 5.36 5.37 5.36 5.36 5.36 5.36 5.36
PV UFCF
SUM PV UFCF -10.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -10
Net Debt -34
Equity Value 24
Diluted Shares Outstanding, MM 80
Equity Value Per Share 0.30

What You Will Get

  • Pre-Filled Financial Model: Cogent Biosciences’ actual data enables precise DCF valuation.
  • Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers.
  • Instant Calculations: Automatic updates ensure you see results as you make changes.
  • Investor-Ready Template: A refined Excel file designed for professional-grade valuation.
  • Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts.

Key Features

  • Customizable Research Parameters: Adjust essential inputs such as drug development timelines, market penetration rates, and R&D expenditures.
  • Instant Valuation Calculations: Provides real-time assessments of intrinsic value, NPV, and additional metrics.
  • High-Precision Analytics: Leverages Cogent Biosciences’ real-world data for accurate valuation insights.
  • Effortless Scenario Modeling: Evaluate various hypotheses and analyze results with ease.
  • Efficiency Booster: Streamlines the process, removing the need for complex financial modeling from the ground up.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Cogent Biosciences, Inc.'s (COGT) preloaded data.
  • 2. Adjust Key Inputs: Modify essential parameters such as revenue growth rates, discount rates, and research & development expenditures.
  • 3. Analyze Results in Real-Time: The DCF model automatically computes intrinsic value and net present value (NPV).
  • 4. Explore Different Scenarios: Evaluate various projections to understand diverse valuation results.
  • 5. Make Informed Decisions: Share expert valuation insights to guide your strategic choices.

Why Choose This Calculator for Cogent Biosciences, Inc. (COGT)?

  • Precision: Utilizes accurate financial data specific to Cogent Biosciences.
  • Adaptability: Tailored for users to easily adjust and experiment with inputs.
  • Efficiency: Eliminates the need to create a financial model from the ground up.
  • High-Quality: Crafted with the expertise and standards expected by industry professionals.
  • Intuitive: Simple interface suitable for users without extensive financial modeling knowledge.

Who Should Use Cogent Biosciences, Inc. (COGT)?

  • Investors: Gain insights into innovative therapies with a reliable analysis platform.
  • Healthcare Analysts: Streamline your research with comprehensive data on biotech advancements.
  • Consultants: Tailor presentations or reports efficiently using our customizable templates.
  • Biotech Enthusiasts: Enhance your knowledge of drug development processes through real-case studies.
  • Educators and Students: Utilize it as a valuable resource in biotechnology and finance education.

What the Template Contains

  • Pre-Filled Data: Includes Cogent Biosciences’ historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Cogent Biosciences’ profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.